Stock_Titan Posted - 5 days ago

$IDYA IDEAYA Biosciences to Participate in Upcoming May 2024 Investor Relations Event https://www.stocktitan.net/news/IDYA/ideaya-biosciences-to-participate-in-upcoming-may-2024-investor-t5jbqs4kopw7.html

Stock_Titan Posted - 04/26/24

$IDYA IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/IDYA/ideaya-biosciences-announces-inducement-grants-under-nasdaq-listing-3u5r0ygw1t9w.html

Stock_Titan Posted - 04/24/24

$IDYA IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study https://www.stocktitan.net/news/IDYA/ideaya-biosciences-announces-asco-2024-oral-presentation-for-jj2qhe2bf1wq.html

CDMO Posted - 04/22/24

$IDYA anybody still here? Looking to reenter this baby

DonCorleone77 Posted - 04/22/24

$IDYA Ideaya Biosciences announces selection of move-forward expansion dose for IDE397 Ideaya Biosciences announced selection of a move-forward Phase 2 expansion dose for IDE397 monotherapy in MTAP-deletion squamous non-small cell lung cancer, or NSCLC, based on adverse event profile and preliminary clinical efficacy observed, including multiple partial responses by RECIST 1.1.

Stock_Titan Posted - 04/22/24

$IDYA IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancer https://www.stocktitan.net/news/IDYA/ideaya-biosciences-announces-selection-of-move-forward-phase-2-1c6q21aiof78.html

G101SPM Posted - 04/15/24

#SHOWTIME Stifel Virtual Targeted Oncology (April 16) Scheduled to appear: $IDYA, $ZYME Moody's Corporation Annual General Meeting (April 16) Scheduled to appear: $MCO First Moline Finl Corp Com Annual General Meeting (April 16) Scheduled to appear: $USB Spotify Technology SA Annual General Meeting (April 16) Scheduled to appear: $SPOT

Stock_Titan Posted - 1 month ago

$IDYA IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/IDYA/ideaya-biosciences-announces-inducement-grants-under-nasdaq-listing-zvvdno3xhf75.html

Stock_Titan Posted - 1 month ago

$IDYA IDEAYA Biosciences to Participate in Upcoming April 2024 Investor Relations Event https://www.stocktitan.net/news/IDYA/ideaya-biosciences-to-participate-in-upcoming-april-2024-investor-qljml4y2y89s.html

TipRanks Posted - 03/27/24

TipRanks’ ‘Perfect 10’ List: These 3 Top-Scoring Stocks Are Sending a Bullish Signal https://www.tipranks.com/news/article/tipranks-perfect-10-list-these-3-top-scoring-stocks-are-sending-a-bullish-signal $RAMP $BBIO $IDYA

Thestocktraderhubzee Posted - 03/22/24

WATCHLIST MAR 22 2024.. $OGS Morgan Stanley Maintains Equal-Weight on ONE Gas, Raises Price Target to $58 $PAYO Citigroup Maintains Buy on Payoneer Global, Lowers Price Target to $6 $TIGR Citigroup Maintains Buy on UP Fintech Holding, Lowers Price Target to $6.22 $IDYA Citigroup Maintains Buy on IDEAYA Biosciences, Raises Price Target to $60 $CXW Wedbush Reiterates Outperform on CoreCivic, Maintains $18 Price Target

Quantumup Posted - 03/21/24

Citi⬆️ $IDYA $60 was $40/rBuy+Top Pick~doesn't believe rally over: +s IDE161 in HRD solid tumors2value; believe further upside will be catalyzed by multi-readouts4daro; reg guide on a pivotal study design; updates from IDE161 Ph1/2/daro 1L MUM pivotal ('24); joint strategy w/ $AMGN $imcr $tngx $bmy

FlynancialAnalyst Posted - 03/19/24

$IDYA rising institutional ownership for this name and low volume rinse into 10 wk SMA looks promising $XBI $IWM $IWO $VOT

DonCorleone77 Posted - 03/12/24

$IDYA $MRK Ideaya enters supply agreement with Merck to evaluate IDE161, Keytruda Ideaya Biosciences (IDYA) announced that it has entered into a clinical trial collaboration and supply agreement with Merck (MRK) to evaluate IDE161, the company's investigational, potential first-in-class, small molecule poly glycohydrolase, or PARG, inhibitor, in combination with Keytruda Merck's anti-PD-1 therapy, in patients with microsatellite instability-, or MSI-, high and microsatellite stable, or MSS, endometrial cancer, in a Phase 1 clinical trial.

Stock_Titan Posted - 03/12/24

$IDYA IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer https://www.stocktitan.net/news/IDYA/ideaya-announces-clinical-collaboration-to-evaluate-ide161-in-feuabtztvcos.html

Quantumup Posted - 03/08/24

BTIG🏁 $IDYA Buy/$55~Co has a robust pipeline of FiC molecules in onc mkts + Strong Balance Sheet. Daro' has shown +VE clin data in the untapped HLA-A2(-) uveal melanoma pt pop, who are ineligible for tx w/ $IMCR 's Buy/$91) KIMMTRAK; +VE'ly views IDE397 as differentiated/pot BiC. $amgn $bmy $tngx

StockConsultant Posted - 2 months ago

$IDYA Ideaya Biosciences stock range breakout watch above 47.53 , see https://stockconsultant.com/?IDYA

Stock_Titan Posted - 2 months ago

$IDYA IDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations Events https://www.stocktitan.net/news/IDYA/ideaya-biosciences-to-participate-in-upcoming-march-2024-investor-pzugmn9lnfac.html

NorthWestHawk Posted - 02/28/24

... By the way, congrats to all that profited when HOOK (first) and then MREO (second) doubled in price after the Nov 18th, 2023 poll (see attached). Clue: Study past Traits they shared with $AXSM, $IDYA, $RYTM, and $XENE that had risen 10X

bitra Posted - 02/24/24

@markovb343 check $IDYA

briefingcom Posted - 02/20/24

$IDYA: IDEAYA Biosciences misses by $0.05, misses on revs https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240220060420IDYA&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

DonCorleone77 Posted - 02/20/24

$IDYA Ideaya Biosciences reports Q4 EPS (52c), consensus (47c) "We believe the ongoing clinical advancement of darovasertib in neoadjuvant Uveal Melanoma, IDE397 and AMG 193 clinical combination in MTAP solid tumors, and IDE161 and GSK101 both in HRD solid tumors, represent important clinical initiatives for IDEAYA in 2024 as potential first-in-class opportunities that address high unmet medical needs. Next, we are targeting this year the Werner IND-filing and multiple development candidate nominations, including in MTAP, representing 7 or more potential first-in-class programs and further advancing our vision to build a leading precision medicine oncology company," said Yujiro Hata, president and CEO, Ideaya Biosciences.

Stock_Titan Posted - 02/20/24

$IDYA IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update https://www.stocktitan.net/news/IDYA/ideaya-biosciences-inc-reports-fourth-quarter-and-full-year-2023-550gwempxljk.html

Bandidosx Posted - 02/14/24

$IDYA 13g filed

insiderbuyingselling Posted - 02/13/24

$IDYA new insider selling: 2000 shares. http://insiderbuyingselling.com/?t=IDYA

Quantumup Posted - 02/12/24

Piper Sandler🏁 $TNGX OW/$18 $TNGX' MTA-cooperative PRMT5 inhibitor portfolio is well positioned w/in precision oncology. PS sees initial clinical data from MRTX1719 and AMG 193 as establishing *unambiguous clinical PoC 4 class; sees TNG908/TNG462 as pot FiC/BiC opp. $BMY $MRTX $AMGN $IDYA

Sixth_Sense Posted - 02/10/24

$RPTX - 335M $TNGX - 1.26B $IDYA - 3.31B Own all 3 and love all 3, but from a Risk / Reward standpoint, I’m heavy in RPTX. Synthetic Lethality is still scratching the surface of its potential and each of these names are BO candidates in the near future. Some nice deals already in place, but sky is the limit for more deals to come as well. Good luck fellow longs!

insiderbuyingselling Posted - 3 months ago

$IDYA new insider selling: 628 shares. http://insiderbuyingselling.com/?t=IDYA

Showmethemoony Posted - 3 months ago

$IDYA Price has doubled in the last 6 months, what a BEAST!!

phatsuit Posted - 01/29/24

$IDYA oh yes